05.09.2016 13:45
The Nyon-based Life Science start-up, Elanix Biotechnologies AG, specialising in tissue regeneration products, has achieved significant milestones in the past months. Among them is the closing of two financing rounds totalling to EUR 1.5 Million. The funds will enable the start-up to enter in the next operative intensive stage.